You are on page 1of 6

.

LPL - PSC-PATPARGANJ
SHOP NO. G3 & G4, AGGARWAL TOWER, LSC
- 2, IP - EXTENSION, PATPARGANJ, ADJ. SBI
DELHI

Name : Mr. PARAS NATH UPADHYAY Collected : 30/3/2017 7:35:00AM


Received : 30/3/2017 7:40:50AM
Lab No. : 134569867 Age: 66 Years Gender: Male Reported : 30/3/2017 4:34:08PM
A/c Status : P Ref By : RML HOSP Report Status : Interim

Test Name Results Units Bio. Ref. Interval

LIPID PROFILE, BASIC, SERUM


(Spectrophotometry, Calculated)
Cholesterol Total 188.00 mg/dL <200.00
Triglycerides 212.00 mg/dL <150.00
HDL Cholesterol 37.10 mg/dL >40.00
LDL Cholesterol 125.00 mg/dL <100.00
VLDL Cholesterol 25.90 mg/dL <30.00
Non-HDL Cholesterol 150.90 mg/dL <130.00
Interpretation
-----------------------------------------------------------------------------------
| NATIONAL LIPID | TOTAL | TRIGLYCERIDE | LDL CHOLESTEROL |NON HDL |
| ASSOCIATION | CHOLESTEROL | in mg/dL | in mg/dL |CHOLESTEROL |
| RECOMMENDATIONS | in mg/dL | | |in mg/dL |
| (NLA-2014) | | | | |
|-------------------|---------------|--------------|-----------------|--------------|
| Optimal | <200 | <150 | <100 | <130 |
|-------------------|---------------|--------------|-----------------|--------------|
| Above Optimal | - | - | 100- 129 | 130 - 159 |
|-------------------|---------------|--------------|-----------------|--------------|
| Borderline High | 200-239 | 150-199 | 130-159 | 160 - 189 |
|-------------------|---------------|--------------|-----------------|--------------|
| High | >=240 | 200-499 | 160-189 | 190 - 219 |
|-------------------|---------------|--------------|-----------------|--------------|
| Very High | - | >=500 | >=190 | >=220 |
-----------------------------------------------------------------------------------

Note
1. Measurements in the same patient can show physiological& analytical variations. Three serial samples
1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. As per NLA-2014 guidelines, all adults above the age of 20 years should be screened for lipid status.
Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
3. Low HDL levels are associated with increased risk forAtherosclerotic Cardiovascular disease (ASCVD)
due to insufficient HDL being available to participate in reverse cholesterol transport, the process by
which cholesterol is eliminated from peripheral tissues.
4. NLA-2014identifies Non HDL Cholesterol(an indicator of all atherogeniclipoproteins such as LDL , VLDL,
IDL, Lpa, Chylomicron remnants)along with LDL-cholesterol as co- primary target for cholesterol
lowering therapy. Note that major risk factors can modify treatment goals for LDL &Non HDL.
5. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have
been achieved.
6. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among patients
with moderate risk for ASCVD for risk refinement
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*134569867* Page 1 of 6
.

LPL - PSC-PATPARGANJ
SHOP NO. G3 & G4, AGGARWAL TOWER, LSC
- 2, IP - EXTENSION, PATPARGANJ, ADJ. SBI
DELHI

Name : Mr. PARAS NATH UPADHYAY Collected : 30/3/2017 7:35:00AM


Received : 30/3/2017 7:40:50AM
Lab No. : 134569867 Age: 66 Years Gender: Male Reported : 30/3/2017 4:34:08PM
A/c Status : P Ref By : RML HOSP Report Status : Interim

Test Name Results Units Bio. Ref. Interval

Treatment Goals as per NLA 2014


----------------------------------------------------------------------------------------
| RISK CATEGORY | NON HDL CHLOESTEROL | LDL CHOLESTEROL |APOLIPOPROTEIN B (mg/dL) |
| | (NON HDL-C) (mg/dL) | (LDL-C)(mg/dL) | |
|----------------------|---------------------|-----------------|-------------------------|
| Low/Moderate/High | <130 | <100 | <90 |
|----------------------|---------------------|-----------------|-------------------------|
| Very High | <100 | <70 | <80 |
----------------------------------------------------------------------------------------

KIDNEY PANEL; KFT,SERUM


(Spectrophotometry, Indirect ISE)
Urea 38.00 mg/dL 17.00 - 43.00
Creatinine 1.99 mg/dL 0.67 - 1.17
Uric Acid 5.70 mg/dL 3.50 - 7.20
Calcium, Total 9.30 mg/dL 8.80 - 10.20
Phosphorus 3.40 mg/dL 2.30 - 3.70
Alkaline Phosphatase (ALP) 94 U/L 30 - 120
Total Protein 7.90 g/dL 6.40 - 8.10
Albumin 4.20 g/dL 3.20 - 4.60
A : G Ratio 1.14 0.90 - 2.00
Sodium 134.00 mEq/L 136.00 - 146.00
Potassium 4.57 mEq/L 3.50 - 5.10
Chloride 108.00 mEq/L 101.00 - 109.00

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*134569867* Page 2 of 6
.

LPL - PSC-PATPARGANJ
SHOP NO. G3 & G4, AGGARWAL TOWER, LSC
- 2, IP - EXTENSION, PATPARGANJ, ADJ. SBI
DELHI

Name : Mr. PARAS NATH UPADHYAY Collected : 30/3/2017 7:35:00AM


Received : 30/3/2017 7:40:50AM
Lab No. : 134569867 Age: 66 Years Gender: Male Reported : 30/3/2017 4:34:20PM
A/c Status : P Ref By : RML HOSP Report Status : Interim

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E


(Automated Strip Test, Microscopy)

Physical

Colour Slight Lemon Yellow Pale yellow


Specific Gravity 1.015 1.001 - 1.030
pH 5 5.0 - 8.0

Chemical

Proteins Present 1+(30.0 mg/dL) Nil


Glucose Nil Nil
Ketones Nil Nil
Bilirubin Nil Nil
Urobilinogen Normal Normal
Leucocyte Esterase Positive Negative
Nitrite Negative Negative

Microscopy

R.B.C. 0-1 RBC/HPF Negative


Pus Cells 18-20 WBC/HPF 0-5 WBC / hpf
Epithelial Cells Few Few
Casts Nil Nil /lpf
Crystals Nil Nil
Others Nil -

PatientReportSCSuperPanel.URINE_EXAMINATION_SC (Version: 6)

*134569867* Page 3 of 6
.

LPL - PSC-PATPARGANJ
SHOP NO. G3 & G4, AGGARWAL TOWER, LSC
- 2, IP - EXTENSION, PATPARGANJ, ADJ. SBI
DELHI

Name : Mr. PARAS NATH UPADHYAY Collected : 30/3/2017 7:35:00AM


Received : 30/3/2017 7:40:50AM
Lab No. : 134569867 Age: 66 Years Gender: Male Reported : 30/3/2017 4:34:30PM
A/c Status : P Ref By : RML HOSP Report Status : Interim

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD 6.2 %


(HPLC, NGSP certified)

Interpretation
-------------------------------------------------------------------------------
| As per American Diabetes Association (ADA) |
|-------------------------------------------------------------------------------|
| Reference Group | HbA1c in % |
|-------------------------------|-----------------------------------------------|
| Non diabetic adults >=18 years| <5.7 |
|-------------------------------|-----------------------------------------------|
| At risk (Prediabetes) | 5.7 - 6.4 |
|-------------------------------|-----------------------------------------------|
| Diagnosing Diabetes | >= 6.5 |
|-------------------------------|-----------------------------------------------|
| Therapeutic goals for glycemic| Age > 19 years |
| control | . Goal of therapy: < 7.0 |
| | . Action suggested: > 8.0 |
| | |
| | Age < 19 years |
| | . Goal of therapy: <7.5 |
-------------------------------------------------------------------------------

Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a
diabetic patient who is recently under good control may still have a high concentration of
HbA1c. Converse is true for a diabetic previously under good control but now poorly
controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long
life expectancy and no significant cardiovascular disease. In patients with significant
complications of diabetes, limited life expectancy or extensive co-morbid conditions,
targeting a goal of < 7.0 % may not be appropriate.

Comments
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better
indicator of long term glycemic control as compared to blood and urinary glucose determinations.

ADA criteria for correlation between HbA1c & Mean plasma glucose levels
---------------------------------------
| HbA1c(%) | Mean Plasma Glucose (mg/dL)|
|----------|----------------------------|
| 6 | 126 |
|----------|----------------------------|
| 7 | 154 |
|----------|----------------------------|
| 8 | 183 |
|----------|----------------------------|

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 7)

*134569867* Page 4 of 6
.

LPL - PSC-PATPARGANJ
SHOP NO. G3 & G4, AGGARWAL TOWER, LSC
- 2, IP - EXTENSION, PATPARGANJ, ADJ. SBI
DELHI

Name : Mr. PARAS NATH UPADHYAY Collected : 30/3/2017 7:35:00AM


Received : 30/3/2017 7:40:50AM
Lab No. : 134569867 Age: 66 Years Gender: Male Reported : 30/3/2017 4:34:30PM
A/c Status : P Ref By : RML HOSP Report Status : Interim

Test Name Results Units Bio. Ref. Interval


| 9 | 212 |
|----------|----------------------------|
| 10 | 240 |
|----------|----------------------------|
| 11 | 269 |
|----------|----------------------------|
| 12 | 298 |
---------------------------------------

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 7)

*134569867* Page 5 of 6
.

LPL - PSC-PATPARGANJ
SHOP NO. G3 & G4, AGGARWAL TOWER, LSC
- 2, IP - EXTENSION, PATPARGANJ, ADJ. SBI
DELHI

Name : Mr. PARAS NATH UPADHYAY Collected : 30/3/2017 7:35:00AM


Received : 30/3/2017 7:40:50AM
Lab No. : 134569867 Age: 66 Years Gender: Male Reported : 30/3/2017 4:34:40PM
A/c Status : P Ref By : RML HOSP Report Status : Interim

Test Name Results Units Bio. Ref. Interval


GLUCOSE, FASTING (F), PLASMA 183.00 mg/dL 70.00 - 100.00
(Hexokinase)

Dr. Anil Arora Dr Biswadip Hazarika Dr Himangshu Mazumdar Dr. Nimmi Kansal
MD (Pathology) MD (Pathology) MD (Biochemistry) MD (Biochemistry)
Consultant Pathologist Consultant Pathologist Consultant Biochemist HOD Biochem & IA

Dr. Shalabh Malik


MD (Microbiology)
HOD Micro & Clinical Path

Result/s to follow:
CULTURE, URINE

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*134569867* Page 6 of 6